Plant Health Care PLC
06 March 2006
Immediate release 6 March 2006
Plant Health Care Plc
('PHC' or 'the Group')
Appointment of Finance Director
The Board of Plant Health Care is pleased to announce the appointment of Walter
Bratkowski (aged 51) to the Board as Finance Director on Friday 3 March 2006. Mr
Bratkowski has been serving as PHC's Chief Financial Officer since July 2005.
Prior to joining PHC, Mr Bratkowski was a consultant at Resources Connection, in
Pittsburgh, United States, where he provided financial consulting services that
included strategic and financial planning, merger and acquisition analysis and
Sarbanes-Oxley documentation. Between 1999 and 2003 Mr Bratkowski was Director
of Corporate Development at Tech Data Corporation in Clearwater, Florida, where
he was responsible for mergers, acquisitions and strategic outsourcing
initiatives, including the acquisition of Aslan Group Plc.
Mr Bratkowski started his career at Peat, Marwick, Mitchell & Co, where he was
certified as a Public Accountant. He received a B.S. in Administration and
Management Science and Economics, as well as a Masters in Business
Administration from Carnegie Mellon University. During the 1990's Mr Bratkowski
held positions at Westinghouse Electric Corporation where he was Manager of
Financial Accounting and Business Planning, and at Reese Brothers Inc, where he
was Director of Finance and Planning.
Dr Albert Fischer, non-executive Chairman of PHC commented, 'We are delighted to
welcome Walt to the Board of PHC. Walt has already introduced significant
developments to enhance our financial systems and processes since he joined us,
and his extensive corporate experience will further strengthen the Board at a
time when the Group is looking forward to a period of growth.'
There is no further information to be disclosed under Schedule 2g of the AIM
Rules.
Walter Bratkowski currently holds an option granted under the Plant Health Care
plc Share Option Scheme 2004 ('the Scheme') over 100,000 ordinary shares of 1p
each in PHC ('Ordinary Shares') with an exercise price of 62p per Ordinary
Share. The option was granted on 31 October 2005 and is exercisable between 31
October 2008 and 30 October 2015, subject to the rules of the Scheme and
performance conditions being met. Mr Bratkowski does not currently have an
interest in Ordinary Shares.
-ends-
For further information please contact:
Plant Health Care plc
John Brady, CEO Tel: 001 603 525 3702
Tavistock Communications Tel: 020 7920 3150
Jeremy Carey
Christian Taylor-Wilkinson
Notes to Editors:
About Plant Health Care
Plant Health Care plc ('PHC') is a leading provider of natural products for
plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United
States, PHC currently has approximately 60 employees and has operations in the
US, Mexico, UK, Spain, and the Netherlands.
PHC's products are aimed at the horticulture, agriculture, turf grass,
commercial landscaping and land reclamation industries and are both
environmentally beneficial and on the whole more cost effective than synthetic
chemical alternatives. Through the commercialisation of these products, PHC is
capitalising on current long-term trends toward natural systems and biological
products for plant care and soil and water management uses.
The Company listed on the AIM market of the London Stock Exchange in July 2004.
Ticker symbol is phc.
Web Site: www.planthealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.